1. Home
  2. IQV vs ARES Comparison

IQV vs ARES Comparison

Compare IQV & ARES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IQV
  • ARES
  • Stock Information
  • Founded
  • IQV 1982
  • ARES 1997
  • Country
  • IQV United States
  • ARES United States
  • Employees
  • IQV N/A
  • ARES N/A
  • Industry
  • IQV Biotechnology: Commercial Physical & Biological Resarch
  • ARES Investment Managers
  • Sector
  • IQV Health Care
  • ARES Finance
  • Exchange
  • IQV Nasdaq
  • ARES Nasdaq
  • Market Cap
  • IQV 31.6B
  • ARES 29.9B
  • IPO Year
  • IQV 2013
  • ARES 2014
  • Fundamental
  • Price
  • IQV $177.31
  • ARES $144.88
  • Analyst Decision
  • IQV Strong Buy
  • ARES Buy
  • Analyst Count
  • IQV 18
  • ARES 13
  • Target Price
  • IQV $248.72
  • ARES $171.67
  • AVG Volume (30 Days)
  • IQV 1.5M
  • ARES 2.1M
  • Earning Date
  • IQV 05-01-2025
  • ARES 05-01-2025
  • Dividend Yield
  • IQV N/A
  • ARES 3.09%
  • EPS Growth
  • IQV 2.74
  • ARES N/A
  • EPS
  • IQV 7.49
  • ARES 2.07
  • Revenue
  • IQV $15,405,000,000.00
  • ARES $3,884,781,000.00
  • Revenue This Year
  • IQV $4.30
  • ARES $24.28
  • Revenue Next Year
  • IQV $6.17
  • ARES $23.86
  • P/E Ratio
  • IQV $23.68
  • ARES $69.96
  • Revenue Growth
  • IQV 2.81
  • ARES 6.96
  • 52 Week Low
  • IQV $176.03
  • ARES $125.23
  • 52 Week High
  • IQV $253.84
  • ARES $200.49
  • Technical
  • Relative Strength Index (RSI)
  • IQV 35.22
  • ARES 37.10
  • Support Level
  • IQV $180.00
  • ARES $144.48
  • Resistance Level
  • IQV $188.39
  • ARES $156.40
  • Average True Range (ATR)
  • IQV 4.58
  • ARES 5.43
  • MACD
  • IQV -0.35
  • ARES 1.35
  • Stochastic Oscillator
  • IQV 9.22
  • ARES 36.46

About IQV IQVIA Holdings Inc.

IQVIA is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.

About ARES Ares Management Corporation

Ares Management Corp is an asset management company. It offers investors investment-related advice and strategies for capital growth. The company's operating segments include Credit Group, Private Equity Group, Real Assets, Secondaries Group, and Others. Its Credit Group generates maximum revenue and manages credit strategies across the liquid and illiquid spectrum. Private Equity Group manages investment strategies categorized as corporate private equity, infrastructure and power, and special opportunities, Real Estate Group manages comprehensive equity and debt strategies across real estate & infrastructure investments. The Secondaries Group invests in secondary markets across a range of alternative asset class strategies, including private equity, real estate, infrastructure, & credit.

Share on Social Networks: